Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat and Exemestane in HR+ Advanced Breast Cancer
NCT02115282Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Mar 2014
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of entinostat in breast cancer, sponsored by National Cancer Institute. Started Mar 2014; status: active, not recruiting.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02115282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115282.